News & Updates

Varenicline alone is an adequate therapy for smoking cessation in heavy-drinking smokers, but combining it with naltrexone may provide benefits in terms of drinking outcomes, particularly during the 12-week period of active medication treatment, suggests a study.

Clinical insomnia was reported in one-third of Hong Kong citizens during the third wave of the coronavirus disease 2019 (COVID-19) outbreak, with over 60 percent having persistent insomnia in both the second and third waves, according to a recent longitudinal follow-up study in Hong Kong.

Individuals with mental disorders, specifically schizophrenia, receive fewer screening and lower-quality treatment for cardiovascular disease (CVD), reveals a study.

In individuals with dementia-related psychosis (DRP) who had a response to the oral 5-HT2A* inverse agonist and antagonist pimavanserin, an atypical antipsychotic agent, the risk of relapse was lower among those who continued the drug vs those who stopped it, the phase III HARMONY trial suggests.

Elevated counts of circulating endothelial progenitor cells (cEPCs) are correlated to worse anxiety, more severe depressive symptoms, poorer cognitive performance, greater social disability, and impaired overall mental health in patients with major depressive disorder (MDD), a recent study has found.